manilatimes.net

www.manilatimes.net ·

Neutral

phase ii data from a randomized double blind trial of ligufalimab anti cd47 combination therapy in frontline aml published at eha 2026

USPEC_POLICY1EPU_POLICY_POLICYWB_1614_NUTRITIONAL_PROGRAMSWB_1609_FOOD_AND_IN_KIND_TRANSFERS

Topic context

This topic has been covered 377167 times in the last 30 days across our monitored publishers.

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.

Related stories

About the publisher

manilatimes.net is one of the en-language news outlets that News Analysis aggregates. Coverage from this source appears in our global feed alongside the publisher's own reporting.

Topic context

Interest-rate coverage tracks the policy rates set by central banks. Rate decisions shape borrowing costs across mortgages, business loans and government debt.

phase ii data from a randomized double blind trial of ligufalimab anti cd47 combination therapy in frontline aml published at eha 2026 | manilatimes.net — News Analysis